PATENT CLAIM ANALYSIS

Application Number: 15933739
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting PCSK9 expression, which may be useful for treating, preventing, or ameliorating a disease associated with PCSK9.

Claim (Index 29):
The compound of  claim 11 , further comprising a conjugated moiety and a conjugate linker.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12478488', '14959714', '14149715', '14839580', '14701999']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7880331404911287
- 35 USC 102 Novelty (BERT): 0.5301253945424286
- Combined Prediction Score: 0.7622423658962587
- Mean Citation Score: 352.086664
- Max Citation Score: 362.38525
- Similarity Product: 254.7359253840893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test